+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Amines 1232416-25-9
1232416-25-9,MFCD27976794
Catalog No.:AA000K58

1232416-25-9 | 3-(3-{4-[(methylamino)methyl]phenyl}-1,2-oxazol-5-yl)-5-[4-(propane-2-sulfonyl)phenyl]pyrazin-2-amine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
99%
in stock  
$19.00   $14.00
- +
25mg
98%
in stock  
$188.00   $132.00
- +
100mg
99%
in stock  
$401.00   $281.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA000K58
Chemical Name:
3-(3-{4-[(methylamino)methyl]phenyl}-1,2-oxazol-5-yl)-5-[4-(propane-2-sulfonyl)phenyl]pyrazin-2-amine
CAS Number:
1232416-25-9
Molecular Formula:
C24H25N5O3S
Molecular Weight:
463.5520
MDL Number:
MFCD27976794
SMILES:
CNCc1ccc(cc1)c1noc(c1)c1nc(cnc1N)c1ccc(cc1)S(=O)(=O)C(C)C
Properties
Computed Properties
 
Complexity:
714  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
33  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
7  
XLogP3:
2.3  

Downstream Synthesis Route
1232416-25-9   
5-(4-(isopropylsulfonyl)phenyl)-3-(3-(4-((methylamino)methyl)phenyl)isoxazol-5-yl)pyrazin-2-carboxamide 

[1]EuropeanJournalofMedicinalChemistry,2017,vol.127,p.691-702

N,N-di(tert-butoxycarbonyl)-5-(4-(isopropylsulfonyl)phenyl)-3-(3-(4-methyl)phenylisoxazol-5-yl)pyrazin-2-amine 
  1232416-25-9 

[1]JournalofMedicinalChemistry,2019,vol.62,p.5547-5561

[1]JournalofMedicinalChemistry,2019,vol.62,p.5547-5561

[1]JournalofMedicinalChemistry,2019,vol.62,p.5547-5561

[1]JournalofMedicinalChemistry,2019,vol.62,p.5547-5561

Literature

Title: ATR inhibitors VE-821 and VX-970 sensitize cancer cells to topoisomerase i inhibitors by disabling DNA replication initiation and fork elongation responses.

Journal: Cancer research 20141201

Title: Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.

Journal: Cell death & disease 20121201

Title: Discovery of potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agents.

Journal: Journal of medicinal chemistry 20110414

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1232416-25-9
Building Blocks
More >
Tags:1232416-25-9 Molecular Formula|1232416-25-9 MDL|1232416-25-9 SMILES|1232416-25-9 3-(3-{4-[(methylamino)methyl]phenyl}-1,2-oxazol-5-yl)-5-[4-(propane-2-sulfonyl)phenyl]pyrazin-2-amine